AndrewJLightfootMD

General Surgery • Davenport, IA

Physician

Join to view full profile

Are you Dr. Lightfoot?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 37 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
3319 Spring St
Davenport, IA 52807
Phone+1 563-359-1641

Fax+1 563-359-4634
Is this information wrong?

Summary

Dr. Andrew Lightfoot, MD is a general surgeon in Davenport, Iowa. He is currently licensed to practice medicine in Iowa, Illinois, and Pennsylvania. He is affiliated with Genesis Medical Center - Davenport.

Education & Training

University of Iowa Hospitals and ClinicsResidency, Urology, 2007 - 2013
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2007

Certifications & Licensure

IA State Medical License 2007 - 2026
IL State Medical License 2014 - 2026
PA State Medical License 2013 - 2014
American Board of Urology Urology

Publications & Presentations

PubMed

12 citations
Does previous transurethral prostate surgery affect oncologic and continence outcomes after RARP
Yu-Kai Su, Benjamin F. Katz, Shailen Sehgal, Sue-Jean S. Yu, Yu-Chen Su, Andrew J. Lightfoot, Ziho Lee, Elton Llukani, Kelly Monahan, David I. Lee> ;Journal of Robotic Surgery. 2015 Aug 8
14 citations
Positive Surgical Margin Trends In Patients With Pathologic T3 Prostate Cancer Treated With Robot Assisted Radical Prostatectomy.
Andrew J. Lightfoot, Yu-Kai Su, Shailen Sehgal, Ziho Lee, Giovanni H. Greaves, Sue-Jean S. Yu, Elton Llukani, Yu-Chen Su, David I. Lee> ;Journal of Endourology. 2014 Dec 15
Positive Surgical Margin Trends In Patients With Pathologic T3 Prostate Cancer Treated With Robot Assisted Radical Prostatectomy.
Lightfoot, A. J.,Su, Y. K.,Sehgal, S. S.,Lee, Z.,Greaves, G. H.,Yu, S. J.,Llukani, E.,Su, Y. C.,Lee, D.> ;J. Endourol.. 2014 Oct 31
71 citations
Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non–muscle invasive bladder cancer
Andrew J. Lightfoot, Benjamin N. Breyer, Henry M. Rosevear, Bradley A. Erickson, Badrinath R. Konety, Michael A. O’Donnell> ;Urologic Oncology. 2014 Jan 1
10 citations
Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer.
Andrew J. Lightfoot, Henry M. Rosevear, Kenneth G. Nepple, Michael A. O’Donnell> ;International Journal of Urology. 2012 Nov 1
60 citations
Utility of the RENAL nephrometry scoring system in the real world: predicting surgeon operative preference and complication risk.
Henry M. Rosevear, Paul Gellhaus, Andrew J. Lightfoot, Timothy P. Kresowik, Fadi N. Joudi, Chad R. Tracy> ;BJU International. 2012 Mar 1
43 citations
Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy.
Lyse A. Norian, Timothy P. Kresowik, Henry M. Rosevear, Britnie R. James, Timothy R. Rosean, Andrew J. Lightfoot, Tamara A. Kucaba, Christopher Schwarz, Christine J. W...> ;Plos One. 2012 Feb 1
Index of Suspicion * Case 1: Voiding difficulty in a 10-year-old * Case 2: Seizure-like activity precipitated by loud noise in a 2-year-old * Case 3: purplish-brown, s...
Henry M. Rosevear, Andrew J. Lightfoot, Charles R Powell, Pedro Weisleder, Jorge Vidaurre, Nathan Lehman, L. Nandini Moorthy> ;Pediatrics in Review. 2011 Oct 1
31 citations
Factors affecting response to bacillus Calmette-Guérin plus interferon for urothelial carcinoma in situ.
Henry M. Rosevear, Andrew J. Lightfoot, Kevin K. Birusingh, José L. Maymí, Kenneth G. Nepple, Michael A. O’Donnell> ;The Journal of Urology. 2011 Sep 1
14 citations
Current and Future Need for Academic Urologists in the United States
Andrew J. Lightfoot, Henry M. Rosevear, William D. Steers, Chad R. Tracy> ;The Journal of Urology. 2011 Jun 1
13 citations
Utility of 18F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes
Henry M. Rosevear, Hadyn T. Williams, Matthew H. Collins, Andrew J. Lightfoot, Teresa A. Coleman, James A. Brown> ;Urologic Oncology. 2012 Sep 1
22 citations
Recognition and treatment of BCG failure in bladder cancer.
Andrew J. Lightfoot, Henry M. Rosevear, Michael A. O’Donnell> ;Thescientificworldjournal. 2011 Mar 7
1 citations
Rubin H. Flocks and colloidal gold treatments for prostate cancer.
Henry M. Rosevear, Andrew J. Lightfoot, Michael A. O’Donnell, Charles E. Platz, Stefan A. Loening, Charles E. Hawtrey> ;Thescientificworldjournal. 2011 Jan 1
20 citations
Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intr...
Henry M. Rosevear, Andrew J. Lightfoot, Kenneth G. Nepple, Michael A. O’Donnell> ;The Journal of Urology. 2011 Jan 1
86 citations
Bacillus Calmette-Guérin with or without interferon α-2b and megadose versus recommended daily allowance vitamins during induction and maintenance intravesical treatme...
Kenneth G. Nepple, Andrew J. Lightfoot, Henry M. Rosevear, Michael A. O’Donnell, Donald L. Lamm> ;The Journal of Urology. 2010 Nov 1
4 citations
Inflatable penile prostheses: an update
Andrew J. Lightfoot, Henry M. Rosevear, Karl J. Kreder> ;Current Opinion in Urology. 2010 Nov 1
8 citations
Safety and efficacy of intravesical bacillus Calmette-Guérin plus interferon α-2b therapy for nonmuscle invasive bladder cancer in patients with prosthetic devices.
Henry M. Rosevear, Andrew J. Lightfoot, Kenneth G. Nepple, Michael A. O’Donnell> ;The Journal of Urology. 2010 Nov 1
13 citations
Lessons Learned from a Case of Calf Compartment Syndrome After Robot-Assisted Laparoscopic Prostatectomy
Henry M. Rosevear, Andrew J. Lightfoot, Marta Zahs, Steve W. Waxman, Howard N. Winfield> ;Journal of Endourology. 2010 Oct 10
26 citations
Conatumumab, a fully human mAb against death receptor 5 for the treatment of cancer
Henry M. Rosevear, Andrew J. Lightfoot, Thomas S. Griffith> ;Current Opinion in Investigational Drugs. 2010 Jun 1
38 citations
The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder
Henry M. Rosevear, Andrew J. Lightfoot, Michael A. O’Donnell, Thomas S. Griffith> ;Cancer Metastasis Reviews. 2009 Dec 5
18 citations
Fluorescent Viability Stains Overestimate Chondrocyte Viability in Osteoarticular Allografts
Andrew Lightfoot, James A. Martin, Annunziato Amendola> ;The American Journal of Sports Medicine. 2007 Nov 1
29 citations
Treatment of postoperative ileus after bowel surgery with low-dose intravenous erythromycin.
Andrew J. Lightfoot, Mary Eno, Karl J. Kreder, Michael A. O’Donnell, Satish S.C. Rao, Richard D. Williams> ;Urology. 2007 Apr 1
9 citations
ACL tears in collegiate wrestlers: report of six cases in one season.
Andrew Lightfoot, Todd O. McKinley, Matthew Doyle, Annunziato Amendola> ;The Iowa Orthopaedic Journal. 2005 Jan 1
28 citations
PEMF as treatment for delayed healing of foot and ankle arthrodesis.
Charles L. Saltzman, Andrew Lightfoot, Annunziato Amendola> ;Foot & Ankle International. 2004 Nov 1
Join now to see all

Press Mentions

Procarta Receives CARB-X Award of up to $9.2 MillionSeptember 17th, 2019
Procarta Raises €1.5 Million to Develop a New Class of Antibiotics to Combat Antimicrobial ResistanceMarch 5th, 2019
EU Referendum: Now Top Life Science Bosses Warn of Brexit Risk, Including GSK, AstraZeneca and Pfizer in Open LaterMay 8th, 2016

Hospital Affiliations

Genesis Medical Center - DavenportDavenport, Iowa